Engineering Non-Human RNA Viruses for Cancer Therapy

Alongside the development and progress in cancer immunotherapy, research in oncolytic viruses (OVs) continues advancing novel treatment strategies to the clinic. With almost 50 clinical trials carried out over the last decade, the opportunities for intervention using OVs are expanding beyond the old...

Descripción completa

Detalles Bibliográficos
Autores principales: Tur-Planells, Vicent, García-Sastre, Adolfo, Cuadrado-Castano, Sara, Nistal-Villan, Estanislao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611381/
https://www.ncbi.nlm.nih.gov/pubmed/37897020
http://dx.doi.org/10.3390/vaccines11101617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611381/
https://www.ncbi.nlm.nih.gov/pubmed/37897020
http://dx.doi.org/10.3390/vaccines11101617

Ejemplares similares